Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HIKAL CHEMIC Gains 6%; BSE HEALTHCARE Index Down 0.2%
Mon, 14 Oct 11:16

HIKAL CHEMIC Gains 6%; BSE HEALTHCARE Index Down 0.2%Image source: Sefa Ozel/www.istockphoto.com

HIKAL CHEMIC share price has zoomed 6% and is presently trading at Rs 358.1.

Meanwhile, the BSE HEALTHCARE index is at 44,363.7 (down 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 5.2%) and IPCA Labs (up 2.2%).

ALEMBIC PHARMA (down 4.2%) and DR. LAL PATHLABS (down 3.0%) are among the top losers today.

Over the last one year, HIKAL CHEMIC has moved up from Rs 281.3 to Rs 358.1, registering a gain of Rs 76.8 (up 27.3%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,004.5 to 44,363.7, registering a gain of 58.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 171.8%), Glenmark Pharma (up 129.1%) and SUVEN PHARMACEUTICALS (up 111.8%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 81,856.1 (up 0.6%).

The top gainers among the BSE Sensex today are HDFC Bank (up 1.9%) and L&T (up 1.7%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 25,101.5 (up 0.6%). HDFC Bank and Wipro are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,079.4 to 81,856.1, registering a gain of 15,776.7 points (up 23.9%).

HIKAL CHEMIC Financial Update...

HIKAL CHEMIC net profit fell 26.1% YoY to Rs 51 million for the quarter ended June 2024, compared to a profit of Rs 69 million a year ago. Net sales rose 4.8% to Rs 4,068 million during the period as against Rs 3,880 million in April-June 2023.

For the year ended March 2024, HIKAL CHEMIC reported 11.2% decrease in net profit to Rs 696 million compared to net profit of Rs 784 million during FY23. Revenue of the company fell 11.8% to Rs 17,846 million during FY24.

The current Price to earnings ratio of HIKAL CHEMIC, based on rolling 12 month earnings, stands at 65.1.


Equitymaster requests your view! Post a comment on "HIKAL CHEMIC Gains 6%; BSE HEALTHCARE Index Down 0.2%". Click here!